Type I interferons trigger systemic, partial lymphocyte activation in response to viral infection

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• T and B lymphocytes are key components of the adaptive immune system.
• Viral infections trigger complex immune responses to control pathogen spread.
• Early activation markers indicate lymphocyte engagement and response initiation.

Purpose of the Study:

• To investigate the early activation of T and B cells following Semliki Forest virus infection in mice.
• To determine the kinetics and factors influencing lymphocyte activation marker expression.
• To elucidate the role of type I interferons in this rapid immune cell activation.

Main Methods:

• Flow cytometry was used to analyze cell surface expression of activation markers (CD69, CD86, CD25) on T and B cells.
• Mice were infected with varying doses of live Semliki Forest virus or treated with poly(I:C).
• Experiments involved wild-type and type I interferon receptor knockout mice to assess the role of IFN-I.

Main Results:

• A high percentage of T and B cells upregulated CD69 and CD86 within 24 hours post-infection, but not CD25.
• Activation marker expression kinetics and magnitude were dependent on live virus, dose, and viral strain virulence.
• This early lymphocyte activation required type I interferon receptor signaling and correlated with serum IFN-I levels.

Conclusions:

• Virus-induced type I interferon (IFN-I) release triggers rapid, systemic activation of a majority of T and B cells.
• This activation occurs independently of antigen-reactivity, inducing a semi-activated state in lymphocytes.
• Type I IFNs play a crucial role in the immediate, non-specific immune response to viral infections.